» Articles » PMID: 23959307

CYP2J2 and CYP2C19 Are the Major Enzymes Responsible for Metabolism of Albendazole and Fenbendazole in Human Liver Microsomes and Recombinant P450 Assay Systems

Overview
Specialty Pharmacology
Date 2013 Aug 21
PMID 23959307
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Albendazole and fenbendazole are broad-spectrum anthelmintics that undergo extensive metabolism to form hydroxyl and sulfoxide metabolites. Although CYP3A and flavin-containing monooxygenase have been implicated in sulfoxide metabolite formation, the enzymes responsible for hydroxyl metabolite formation have not been identified. In this study, we used human liver microsomes and recombinant cytochrome P450s (P450s) to characterize the enzymes involved in the formation of hydroxyalbendazole and hydroxyfenbendazole from albendazole and fenbendazole, respectively. Of the 10 recombinant P450s, CYP2J2 and/or CYP2C19 was the predominant enzyme catalyzing the hydroxylation of albendazole and fenbendazole. Albendazole hydroxylation to hydroxyalbendazole is primarily mediated by CYP2J2 (0.34 μl/min/pmol P450, which is a rate 3.9- and 8.1-fold higher than the rates for CYP2C19 and CYP2E1, respectively), whereas CYP2C19 and CYP2J2 contributed to the formation of hydroxyfenbendazole from fenbendazole (2.68 and 1.94 μl/min/pmol P450 for CYP2C19 and CYP2J2, respectively, which are rates 11.7- and 8.4-fold higher than the rate for CYP2D6). Correlation analysis between the known P450 enzyme activities and the rate of hydroxyalbendazole and hydroxyfenbendazole formation in samples from 14 human liver microsomes showed that albendazole hydroxylation correlates with CYP2J2 activity and fenbendazole hydroxylation correlates with CYP2C19 and CYP2J2 activities. These findings were supported by a P450 isoform-selective inhibition study in human liver microsomes. In conclusion, our data for the first time suggest that albendazole hydroxylation is primarily catalyzed by CYP2J2, whereas fenbendazole hydroxylation is preferentially catalyzed by CYP2C19 and CYP2J2. The present data will be useful in understanding the pharmacokinetics and drug interactions of albendazole and fenbendazole in vivo.

Citing Articles

Construction of a CYP2J2-Template System and Its Application for Ligand Metabolism Prediction.

Yamazoe Y, Murayama N Food Saf (Tokyo). 2024; 12(4):69-82.

PMID: 39713276 PMC: 11649976. DOI: 10.14252/foodsafetyfscj.D-24-00010.


Repositioning anthelmintics for the treatment of inflammatory-based pathological conditions.

do Nascimento Rodrigues D, Porto J, Dos Santos I, Filho J, Ferreira P Inflammopharmacology. 2024; 33(2):551-571.

PMID: 39589670 DOI: 10.1007/s10787-024-01605-w.


Cytochrome P450 2J2 is required for the natural compound austocystin D to elicit cancer cell toxicity.

Kojima Y, Fujieda S, Zhou L, Takikawa M, Kuramochi K, Furuya T Cancer Sci. 2024; 115(9):3054-3066.

PMID: 39009033 PMC: 11462933. DOI: 10.1111/cas.16289.


CYP2C19 and CYP2J2 genotypes predict praziquantel plasma exposure among Ethiopian school-aged children.

Gebreyesus T, Makonnen E, Telele N, Barry A, Mnkugwe R, Gerba H Sci Rep. 2024; 14(1):11730.

PMID: 38778126 PMC: 11111788. DOI: 10.1038/s41598-024-62669-w.


Population pharmacokinetics of ivermectin after mass drug administration in lymphatic filariasis endemic communities of Tanzania.

Fimbo A, Mlugu E, Kitabi E, Kulwa G, Iwodyah M, Mnkugwe R CPT Pharmacometrics Syst Pharmacol. 2023; 12(12):1884-1896.

PMID: 37638539 PMC: 10725270. DOI: 10.1002/psp4.13038.


References
1.
Lee C, Neul D, Clouser-Roche A, Dalvie D, Wester M, Jiang Y . Identification of novel substrates for human cytochrome P450 2J2. Drug Metab Dispos. 2009; 38(2):347-56. DOI: 10.1124/dmd.109.030270. View

2.
Rawden H, Kokwaro G, Ward S, Edwards G . Relative contribution of cytochromes P-450 and flavin-containing monoxygenases to the metabolism of albendazole by human liver microsomes. Br J Clin Pharmacol. 2000; 49(4):313-22. PMC: 2014938. DOI: 10.1046/j.1365-2125.2000.00170.x. View

3.
Kim K, Kim D, Jang H, Kim M, Kim D, Kim J . Lateral segregation of anionic phospholipids in model membranes induced by cytochrome P450 2B1: bi-directional coupling between CYP2B1 and anionic phospholipid. Arch Biochem Biophys. 2007; 468(2):226-33. DOI: 10.1016/j.abb.2007.10.003. View

4.
Mothe O, Totis M, Masson C, Batt A, DELATOUR P, Siest G . Albendazole sulfonation by rat liver cytochrome P-450c. J Pharmacol Exp Ther. 1988; 246(2):758-64. View

5.
Ha-Duong N, Dijols S, Macherey A, Goldstein J, Dansette P, Mansuy D . Ticlopidine as a selective mechanism-based inhibitor of human cytochrome P450 2C19. Biochemistry. 2001; 40(40):12112-22. DOI: 10.1021/bi010254c. View